FIRST QUARTER REVENUE

 
News Articles for FIRST QUARTER REVENUE top ^
ATLANTA , April 29, 2014 /PRNewswire/ -- First Quarter Highlights: Grew HeRO ® Graft revenues 26 percent year-over-year to $1.6 million Received FDA approval to begin PerClot ® clinical trial Received FDA 510(k) clearance for PerClot Topical Secured distribution rights and purchase option for ProCol ® Vascular Bioprosthesis Established new regional headquarters in Singapore to expand presence in rapidly growing Asia-Pacific medical device market CryoLife, Inc. (NYSE: CRY) , a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the first quarter of 2014.
Sign-up for CryoLife Posts Record First Quarter Revenues of $35.7 Million investment picks
COMPANY ANNOUNCES SECOND QUARTER REVENUE GUIDANCE MARIETTA, Ga.
Sign-up for MiMedx First Quarter Revenue Exceeded Upper End Of Guidance investment picks
ATLANTA , April 15, 2014 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN) , the leading lease-to-own specialty retailer that offers flexible payment options for credit-challenged individuals, today announced it is reducing the Company's 2014 first quarter revenue and earnings guidance.
Sign-up for Aaron's, Inc. Reduces 2014 First Quarter Revenue and Earnings Guidance investment picks
SHANGHAI, China, March 31, 2014 (GLOBE NEWSWIRE) -- Montage Technology Group Limited (Nasdaq:MONT) ("Montage Technology" or "Montage" or the "Company"), a global fabless provider of analog and mixed-signal semiconductor solutions addressing the home entertainment and cloud computing markets, today announced preliminary revenue results for the first quarter 2014 of $34.5 to $36.5 million, exceeding the previously announced guidance of $29.0 to $32.0 million.
Sign-up for Montage Technology Announces Preliminary First Quarter Revenue Results Exceeding Guidance investment picks
By Tess Stynes Baidu Inc. (BIDU) said its first-quarter revenue rose 59%, topping expectations, driven by growth in the company's core search business.
Sign-up for Baidu first-quarter revenue rises 59% investment picks
NEW YORK (MarketWatch) -- Pfizer Inc. (PFE) said Monday its first-quarter earnings fell to $2.33 billion, or 36 cents a share, from $2.75 billion, or 38 cents a share in the year-earlier period.
Sign-up for Pfizer first-quarter revenue misses expectations investment picks
2014/5/7
HOUSTON , May 7, 2014 /PRNewswire/ -- Sanchez Energy Corporation (NYSE: SN) (the "Company" or "Sanchez Energy"), today announced the Company's operating and financial results for the first quarter 2014, which included the following highlights: HIGHLIGHTS FOR FIRST QUARTER 2014 Record revenues of $134.6 million , an increase of 334% over the same period a year ago Adjusted EBITDA, a non-GAAP financial measure defined below, of $96.2 million , an increase of 358% over the same period a year ago Adjusted Net Income, a non-GAAP financial measure defined below, of $9.0 million , an increase of 110% compared to the same period a year ago Liquidity of $436 million as of March 31, 2014 consisting of $400 million in undrawn capacity on our secured revolving credit facility (with a $325 million elected commitment amount), and $111 million in cash and cash equivalents Substantial
Sign-up for Sanchez Energy Announces First Quarter 2014 Financial Results and Updates Operations; Record First Quarter Revenues Rise 334% on 376% Higher Production investment picks
GIVAT SHMUEL, Israel , May 14, 2014 /PRNewswire/ -- Cimatron Limited (NASDAQ: CIMT) , a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced its financial results for the first quarter of 2014.
Sign-up for Cimatron Reports $11 Million Revenues in Q1/14, Marking Record First Quarter Revenues, Operating Profit and Cash Flow investment picks
DECLARES 71st CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass.
Sign-up for Psychemedics Corporation Announces Record First Quarter Revenues investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

FIRST QUARTER REVENUE
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: First Quarter Results  |  Next: First Quarter Sales